Who
Stefan Lutz
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Codexis.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $36K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Jan 2026
- Last trade
- 24 Feb 2026
- Last filed
- 25 Feb 2026
Companies traded
Activity over time
1 Jan – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Feb 2026filed 25 Feb 2026 | CDXS CodexisChemicals | SEC FORM 4 Sold | $6,6415,862 at $1.13 | filing |
| 24 Feb 2026filed 25 Feb 2026 | CDXS CodexisChemicals | SEC FORM 4 Sold | $6,6245,862 at $1.13 | filing |
| 23 Feb 2026filed 25 Feb 2026 | CDXS Codexisoption or derivative · Chemicals | SEC FORM 4 Code A | —316,100 at $0.00 | filing |
| 23 Feb 2026filed 25 Feb 2026 | CDXS Codexisoption or derivative · Chemicals | SEC FORM 4 Code A | —316,100 at $0.00 | filing |
| 6 Feb 2026filed 9 Feb 2026 | CDXS CodexisChemicals | SEC FORM 4 Sold | $3,2572,492 at $1.31 | filing |
| 6 Feb 2026filed 9 Feb 2026 | CDXS CodexisChemicals | SEC FORM 4 Sold | $3,2652,492 at $1.31 | filing |
| 7 Jan 2026filed 8 Jan 2026 | CDXS CodexisChemicals | SEC FORM 4 Sold | $7,9504,685 at $1.70 | filing |
| 7 Jan 2026filed 8 Jan 2026 | CDXS CodexisChemicals | SEC FORM 4 Sold | $7,9654,685 at $1.70 | filing |
News
Codexis (NASDAQ:CDXS) and Revvity (NYSE:RVTY) Head-To-Head ComparisonCDXS · themarketsdaily.com · 19 Oct 2026
0 headlines in the last 90 days name Stefan Lutz; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.